Recent AUPH Stock Price | AUPH Stock Predictions | |
$4.92 | +114.84% |
$10.57 |
Recent AUPH Analyst Ratings Breakdown, Making AUPH Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 4 | 4 | 4 | 5 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 2 | 2 | 2 | 2 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.71 | 1.71 | 1.71 | 1.63 |
For the AUPH stock predictions from the analysts covering Aurinia Pharmaceuticals Inc, we have collected all of the individual AUPH stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 7 different analysts covering AUPH (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since AUPH stock predictions may vary widely, another useful metric to consider is the median AUPH stock prediction, which represents the price at which half of the analysts
made AUPH stock predictions that were higher and half made AUPH stock predictions that were lower. This makes for a different take on the AUPH stock predictions out there, as compared to average or mean.
And that median across all the individual AUPH stock predictions was: $10.0 as of 2024-04-18.
The very highest of the AUPH stock predictions for one year price target was $15.0, while the very lowest of the AUPH stock predictions in the analyst group was
$8.0 (with a standard deviation of $2.636). Get the latest Zacks research report on AUPH — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
FELE Stock Predictions
WLL Stock Predictions
RDHL Stock Predictions
GRA Stock Predictions
BXC Stock Predictions
LRCX Stock Predictions
NAT Stock Predictions
WST Stock Predictions
CNOB Stock Predictions
|
|
Buy (3.29 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |